OUR
FOCUS
We are working in collaboration with leading scientists, academia, industry and non-governmental organisations to establish sustainable and affordable development pathways for diagnostics and therapeutics for infectious disease and cancer. We also consult and engage with grassroots healthcare community champions to ensure our programmes benefit patients and communities globally. Some publications from CADT members.
Infectious Disease
Affordable diagnostics. Over the course of the pandemic, we gained experience as academics working with industry partners, GADx and QuantuMDx to develop and validate point of care diagnostics for SARS-CoV-2. We now collaborating on diagnostic development programmes for dengue, malaria, yellow fever, ebola, nipah and Human Papilloma Virus (HPV).
Global Health
Community empowerment. We are working with community healthcare champions to improve women’s health in Sarawak (on the island of Borneo) in Malaysia. At present, we are focused on breast and cervical screening and maternal health initiatives for under served women in rural Sarawak. We collaborate closely with Programme ROSE on HPV-DNA cervical self-sampling for cervical cancer and are also training local women to become Know Your Lemons community educators for early breast cancer detection.
Cancer
Drug repurposing for cancer. Drug discovery and novel drug development takes on average 10-15 years to go from bench to clinic at an average cost of USD1 billion. Repurposing of 'old' drugs for new indications can shorten this pathway substantially with significant cost savings.
We have developed an artemisinin drug repurposing programme for a number of cancers.
Our consortium has a number of clinical trials in development for cervical cancer, nasopharyngeal cancer, Acute Myeloid Leukaemia, and multinational studies on colorectal cancer.
We have strong industry collaborations with specialised pharmaceutical development companies focused on drug repurposing and repositioning.